Cargando…
Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
Autores principales: | Pértega-Gomes, Nelma, Vízcaíno, José R, Miranda-Gonçalves, Vera, Lopes, Carlos, Baltazar, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624157/ http://dx.doi.org/10.1186/1753-6561-7-S2-P53 |
Ejemplares similares
-
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011) -
Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014) -
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
por: Pertega‐Gomes, Nelma, et al.
Publicado: (2015) -
Exploiting monocarboxylate transporters as new molecular targets for colorectal carcinoma therapy
por: Amorim, Ricardo, et al.
Publicado: (2013) -
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014)